Comprehensive medication guide to Qulipta including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$50 copay with commercial insurance; prior authorization and step therapy typically required.
Estimated Cash Pricing
$1,185–$1,600 per 30-day supply at retail; eligible patients may pay $0 with the Qulipta Complete Savings Card.
Medfinder Findability Score
55/100
Summarize with AI
On this page
Qulipta (Atogepant) is a prescription oral medication manufactured by AbbVie used for the preventive treatment of episodic and chronic migraine in adults. It belongs to a class of drugs called CGRP receptor antagonists (gepants). Unlike injectable migraine preventives, Qulipta is taken as a once-daily tablet, making it a convenient option for patients who prefer oral medications. It was FDA-approved in September 2021 for episodic migraine and later expanded to include chronic migraine prevention.
Qulipta works by blocking calcitonin gene-related peptide (CGRP) receptors in the brain. CGRP is a neuropeptide that plays a central role in triggering migraine attacks — it promotes vasodilation, neurogenic inflammation, and pain signal transmission in the trigeminal system. By antagonizing CGRP receptors, Qulipta helps prevent the cascade of events that leads to migraine, reducing the frequency and severity of attacks over time.
![Why Is Qulipta So Hard to Find? [Explained for 2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2Fa3e2bc8423f6b8aec8cb764bcc89a8bbd0bb78ba-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)
![How to Find a Doctor Who Can Prescribe Qulipta Near You [2026 Guide]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F7780fb74a1b0bfda320fa918ebca916ab454222a-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
10 mg tablet — tablet
once daily (lower dose for episodic migraine, or when used with strong CYP3A4 inhibitors)
30 mg tablet — tablet
once daily (for episodic migraine)
60 mg tablet — tablet
once daily (for episodic or chronic migraine)
Qulipta scores a 55 out of 100 on our findability scale, meaning it can be moderately difficult to locate. While Qulipta is not on the FDA Drug Shortage list, it is a brand-name-only specialty medication with no generic alternative available. Many pharmacies don't routinely stock it, and patients often need to call multiple locations or use specialty pharmacies. Insurance prior authorization delays can further complicate access. Using Medfinder can help you quickly locate pharmacies that have Qulipta in stock near you.
Qulipta can be prescribed by several types of healthcare providers, including:
Telehealth providers can also prescribe Qulipta, making it accessible even if you don't have a local specialist.
No. Qulipta is not a controlled substance and has no DEA scheduling. It does not carry a risk of abuse or dependence. No special prescribing restrictions apply — it can be prescribed with a standard prescription and refilled normally.
Most side effects are mild and tend to improve over the first few weeks of treatment. Serious but rare side effects include hypersensitivity reactions, elevated blood pressure, and liver enzyme elevations. Contact your doctor if you experience swelling of the face, lips, or throat, or any signs of an allergic reaction.
Know what you need? Skip the search.
Nurtec ODT (Rimegepant)
another oral CGRP antagonist, taken as a 75 mg dissolving tablet every other day for prevention (also approved for acute migraine treatment)
Aimovig (Erenumab)
injectable CGRP receptor antibody, given as a monthly subcutaneous injection (70 mg or 140 mg)
Ajovy (Fremanezumab)
injectable CGRP antibody, available as a monthly (225 mg) or quarterly (675 mg) subcutaneous injection
Emgality (Galcanezumab)
injectable CGRP antibody, given monthly (120 mg after a 240 mg loading dose)
Topiramate, Propranolol, Amitriptyline
older generic oral preventives that insurers often require patients to try first
Prefer Qulipta? We can find it.
Strong CYP3A4 inhibitors
moderate(Ketoconazole, Itraconazole, Clarithromycin) — dose must be reduced to 10 mg daily for episodic migraine; avoid use for chronic migraine
Strong CYP3A4 inducers
moderate(Rifampin, Carbamazepine, Phenytoin, St. John's Wort) — may reduce Qulipta effectiveness; dose adjustments required
OATP inhibitors
moderate(Cyclosporine, single-dose Rifampin) — may increase Qulipta levels; dose reduction recommended
Qulipta is a valuable oral option for migraine prevention, offering a convenient once-daily tablet as an alternative to injectable CGRP therapies. While its brand-name-only status and high retail price can make access challenging, manufacturer savings programs and insurance coverage can significantly reduce out-of-pocket costs. If you're having trouble finding Qulipta at your local pharmacy, try using Medfinder to check real-time availability near you.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini